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ABSTRACT 
Infection with high-risk human papillomavirus (HPV) is responsible for nearly all cases 
of cervical cancer, as well as a significant fraction of other ano-genital and head and neck 
cancers. Specifically, HPV type 16 (HPV 16) causes the majority of cervical cancers 
attributed to HPV infection. Intratypic variation occurs within the HPV 16 genome such 
that naturally occurring variants have been described that display variable risks in 
promoting cervical cancer. In particular, the Asian-American (AA) variant of HPV 16 has 
been found to be a greater risk factor for the development and earlier onset of invasive 
cervical cancer than the European Prototype (EP). Keratinocytes transduced with the AA 
variant were previously shown to have increased levels of glycolytic enzymes, implying 
AAE6 may enhance the Warburg effect - the tendency of cancer cells to take up higher 
levels of glucose and metabolize it to lactate. Therefore, glucose consumption and lactate 
production were assessed in the context of these variants and AAE6 was found to 
enhance the Warburg effect. To elucidate the mechanism behind this shift in metabolism, 
the hypoxia-inducible factor 1 (HIF-1) pathway was investigated. HIF-1 is a 
heterodimeric transcription factor made up of a and (3 subunits, and enhances the 
transcription of genes involved in the Warburg effect. Even under normoxic conditions, 
HIF-1 a is detectable in AAE6 cells, and its levels are higher in the nucleus than in EPE6 
cells. A HIF-1-speeific reporter assay found HIF-1 activity to be greater in AAE6 in 
comparison to EPE6 under hypoxia, a typical hallmark of the tumour microenvironment. 
Gene expression analysis found that the HIF-1 targets GLUTl and VEGF-A are induced 
to a greater degree in AAE6 cells exposed to hypoxia. Future studies can elucidate the 
functionality of HIF-1 in AAE6’s enhanced invasive potential via RNA-interference. 
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LAY SUMMARY 
Faculty and students in the Department of Biology are bound together by a common 
interest in explaining the diversity of life, the fit between form and function, and the 
distribution and abundance of organisms. This particular study sought to understand, on a 
cellular level, the variation in the cancer-eausing potential of two genetie variants of 
human papillomavirus (HPV) type 16 - a sexually transmitted virus capable of causing 
cancers of the ano-genital region. The E6 oncogene is one of the major HPV genes 
responsible for causing cancer. In this study, the E6 gene of the European Prototype and 
the more aggressive Asian-American HPV 16 variant, were investigated with regards to 
how they affect host cell sugar metabolism and ability to adapt to tumour hypoxia. These 
interrelated properties are known to influenee the ability of cells to progress through the 
stages of carcinogenesis. The more aggressive HPV 16 E6 Asian-American variant 
exemplified a metabolism conducive to cancer progression, and also adaptive to hypoxia, 
a condition that arises in many cancers and consequently may promote eaneer further. 
This study furthers our understanding of human papillomavirus biology, while also 
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1 INTRODUCTION 
1.1 Human Papillomaviruses and Cancer 
Approximately 16% of yearly cancer diagnoses worldwide are attributable to an 
infectious agent, the majority of which are the result of a viral infection (de Martel et al., 
2012). One of the most well established links between a viral infection and cancer is that 
of the human papillomaviruses (HPVs), which cause cancers of the ano-genital region 
and oral mucosa. Notably, it is estimated that infection with HPV is responsible for up to 
99.7% of cervical cancer cases - the second most common type of cancer among women 
worldwide (Walboomers et al., 1999). While over 170 types of HPVs have been 
identified, only a small fraction are associated with persistent infection leading to cervical 
cancer, and thus termed “high-risk” to differentiate them from the “low-risk” types that 
cause benign warts. Furthermore, of the cervical cancer cases that result from HPV 
infection, more than half (approximately 55%) result from infection with HPV type 16 
(HPV16) (Crow et al., 2012). 
The human papillomaviruses are double stranded DNA viruses with a genome 
that is approximately eight kilobases in length. It contains eight open reading frames 
(ORFs) under transcriptional regulation of a long control region or upper regulatory 
region (LCR/URR) (Figure 1). The LCR contains transcription factor binding sites for 
both viral and endogenous host transcription factors. The genome contains six genes 
expressed early in the viral life cycle (“E” genes) that are responsible for viral replication, 
and two late (“L”) genes that code for the viral capsid. The HPV viral life cycle entails 
virions gaining entry to basal keratinocytes, typically through microscopic abrasions in 
the epithelium. At this point, the viral capsid is digested and the early genes of the virus 
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Figure 1. The organization of the human papillomavirus type 16 genome. The LCR 
has binding sites for host cell transcription factors as well as viral proteins E1 and E2 that 
control viral replication and gene expression. P97, Early promoter; P670, Late promoter. 
Adapted with publisher permission from Ghittoni et al., 2010. 
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are expressed (Figure 2) (Doorbar et al., 2012). As basal keratinocytes divide, they give 
rise to daughter cells that move outward toward the epithelial surface. Once cells reach 
the surface of the epithelium, they express the L2 and LI proteins, and subsequent 
packaging and release of new virions into the surrounding environment occurs (Doorbar 
et al., 2012). 
The two major viral genes that act to induce malignancy in infected cells are the 
E6 and E7 oncogenes. To date, many cellular functions of these two oncogenes have been 
elucidated. The E7 gene of high-risk HPV types effectively binds to and deactivates the 
retinoblastoma tumour suppressor (pRb) protein. The binding of E7 to pRb releases the 
transcription factors of the E2F family that, in turn, push the cell into the S phase of the 
cell cycle, thus promoting cell proliferation (Ghittoni et al., 2010). The E6 gene of high- 
risk HPV causes the breakdown of the tumour suppressor protein, p53, which normally 
has several anti-tumour effects such as promoting apoptosis and cell cycle arrest (Hock & 
Vousden, 2012). High-risk E6 has several other functions in immortalization (i.e., 
extending cellular lifespan) and cellular transformation (to obtain a malignant phenotype) 
including enhancing telomerase activity (Klingelhutz, et al., 1996), as well as enhancing 
cell proliferation and adhesion (Doorbar et al., 2012). 
1.2 Tumour metabolism 
Termed the Warburg effect after German physiologist Otto Warburg, it has been 
well documented that cancer cells take up large amounts of glucose and convert much of 
it into lactate, as opposed to channeling pyruvate derived from glycolysis into the 
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Figure 2. Infection by HPV and progression to invasive cancer. HPV virions infect 
rapidly dividing basal keratinocytes of the epithelium, upon which early genes are 
expressed and viral DNA is maintained episomally. As infected cells begin to move 
toward the superficial epithelium with altered differentiation, late genes begin to be 
expressed and viral packaging occurs. Over the course of several years, if the infection is 
not cleared by the host immune system, invasive cervical cancer may develop along with 
integration of the HPV genome into host DNA. Adapted with publisher permission from 
Woodman et al., 2007. 
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mitochondria for oxidative phosphorylation (OXPHOS; Figure 3; Vander Heiden et ah, 
2009). This metabolic shift is reminiscent of cells that are under hypoxic stress. In 
normal, well oxygenated and differentiated cells, glucose is metabolized to pyruvate, 
followed by oxidative phosphorylation in order to maximize adenosine triphosphate 
(ATP) production. Under hypoxic conditions, however, where molecular oxygen is not 
available as a final electron acceptor, pyruvate is not converted to acetyl-CoA and 
subsequent oxidative phosphorylation does not occur. 
The advantage bestowed to cancer cells by switching their mode of metabolism 
from one where energy output is maximized, to a much less efficient one in terms of 
energy (ATP) production is still a topic of debate. While it was initially assumed that 
Warburg’s observations of a switch in metabolism of cancer cells from oxidative 
phosphorylation to aerobic glycolysis to arise from a tumour microenvironment that is 
often hypoxic, there is evidence that cancer cells continue to exhibit this type of 
metabolism, even when exposed to sufficient oxygen for oxidative phosphorylation to 
occur (Figure 3; Kondoh 2008; Vander Heiden et ah, 2009). Consequently, it is 
hypothesized that this shift in metabolism to a less efficient mode of energy production 
occurs in proliferating cells to facilitate the transport of nutrients in such a manner that 
promotes cellular proliferation and survival, and not necessarily ATP production (Vander 
Heiden et ah, 2009). Altering metabolism to rely primarily on glycolysis for ATP 
production confers several benefits for tumour growth. First and foremost, cancer cells 
can use the increased glucose influx to provide carbon for the biosynthesis of 
macromolecules (lipids, nucleotides, proteins) required for cellular proliferation 
(Kroemer & Pouyssegur, 2008). For example, glucose-6-phosphate can be used for the 
5 
production of ribose-5-phosphate to be used in nucleotide synthesis via the pentose 
phosphate pathway, while dihydroxyacetone phosphate produced from the glycolytic 
intermediate fructose-1,6-biphosphate is used for the biosynthesis of phospholipids 
(Lopez-Lazaro, 2008). Secondly, alteration of metabolism to aerobic glycolysis favours 
tumourigenesis by circumventing the formation of reactive oxygen species (ROS; e.g., 
O2’, ’OH) resulting from oxidative phosphorylation (Kondoh 2008). Oxidative stress 
induces replicative senescence and apoptosis, so the Warburg effect may select for cells 
that are resistant to senescence that results from oxidative phosphorylation (Hsu & 
Sabatini, 2008). Third, the production of lactic acid lowers the pH of the tumour 
microenvironment Lactic acidosis favours tumour growth and invasion by inducing 
death of normal cells that do not have the typical characteristic of cancer cells to be 
resistant to low pH. This “acid-mediated invasion” also promotes activity and secretion 
of extracellular matrix remodeling enzymes such as cathepsins and matrix 
metalloproteases, while also limiting the immune response to cancer growth, and 
promoting angiogenesis (Gatenby et al., 2006; Parks et al., 2011). Acidification of the 
tumour microenvironment as a result of lactate production is associated with a poor 
clinical outcome and increased risk of metastases (reviewed in Hirschhaeuser et al., 2011; 
Dhup et al., 2012), including those of the uterine cervix (Walenta et al., 2000). 
6 





























-4 mol ATP/mol glucose 
Figure 3. The Warburg Effect. Proliferating tissues, regardless of the level of oxygen 
present, take in glucose and convert much of it to lactate. A large decrease in the amount 
of ATP produced per molecule of glucose accompanies this change in metabolic fate, 
which is accommodated for by increasing the influx of glucose. Used with publisher 
permission from Vander Heiden et al., 2009. 
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1.3 HIF-1 as a regulator of tumour metabolism 
In non-cancerous cells, regulation of anaerobic metabolism relies primarily on the 
direction of the transcription factor, hypoxia-inducible factor 1 (HIF-1) (DeBarardinis et 
aL, 2008). Transcriptionally active HIF-1 is a heterodimer made up of a- and P-subunits 
(the p subunit is also known as aryl hydrocarbon receptor nuclear translocator (ARNT), 
which also dimerizes with several other transcription factor subunits; Bersten et al., 
2013). In most normal, non-hypoxic cells, HIF-la is continually synthesized and 
degraded, while HIF-lp is constitutively expressed to levels that remain relatively 
constant within the nucleus. HIF-1 activity (the ability to induce transcription of genes), 
therefore, is largely dependent on the regulation of its a subunit at several levels 
including transcription, translation, ubiquitin-mediated protein breakdown, nuclear 
translocation, and association with transcriptional co-activators. 
HIF-la mRNA is ubiquitously expressed and its levels are similar for most cell 
types studied, and remain unaltered between hypoxic and normoxic conditions (Wenger 
et al., 1997). However, several growth factors and their associated pathways play a role in 
enhancing HIF-la signalling in an oxygen-independent manner by augmenting the 
translation of HIF-la mRNA to protein. Binding of a growth factor (e.g., insulin-like 
growth factor 1, epidermal growth factor) to its cognate receptor tyrosine kinase (RTK) 
can lead to activation of the PI3K/Akt or MARK pathways. Activation of either of these 
pathways leads to the translation of HIF-la mRNA by acting on the translation initiator 
eIF-4E, stimulating HIF-la protein synthesis in an oxygen-independent manner (Agani 
& Jiang, 2013). 
8 
In normoxic cells, HIF-la protein degradation is initiated by hydroxylation at one 
of its proline residues (Pro-402 or Pro-564) by prolyl hydroxylases (PHD-1, PHD-2, and 
PHD-3) that use molecular oxygen as a co-substrate (Bruick and McKnight, 2001; 
Semenza, 2001). Upon hydroxylation, HIF-la-OH becomes ubiquitinylated by the von 
Hippel Lindau E3 ubiquitin ligase protein (VHL), and subsequent proteasomal 
breakdown occurs. When there is a lack of oxygen, PHDs become obsolete, resulting in 
HIF-la stabilization and accumulation in the cytoplasm. Once HIF-la protein levels 
increase in the cytoplasm it translocates to the nucleus by way of a/p importins that 
require a nuclear localization signal (NFS) sequence in HIF-la’s N-terminus 
transactivation domain (N-TAD, Depping et al., 2008). Once in the nucleus, HIF-la 
dimerizes with HIF-ip followed by complexing with the transcriptional co-activators 
p300/CBP. The formation of the transcription complex is inhibited under hypoxic 
conditions by the hydroxylase, factor inhibiting HIF-1 (FIH). Similar to the PHDs, FIH 
hydroxylates the C-terminal transactivation domain (C-TAD) of HIF-la at Asn-803, 
inhibiting the binding of the heterodimer of HIF-1 to its transcriptional co-activator p300 
(Lando et al., 2002). If each of these HIF-1-regulatory checkpoints are overcome, active 
HIF-1 binds to hypoxia response elements (HREs) in target gene promoters, 
transcriptionally activating a multitude of genes with specific roles in the hypoxic 
response. To date, over 100 HIF-1 targets have been identified. Although several of the 
HIF-1 target genes identified thus far are commonly activated in several cell types in 
response to hypoxia, the specific subset of HIF-1 target genes that are activated under 
hypoxia can vary between cell type, likely due to the epigenetic effects of other 
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transcription factors also acting on HIF-1 target genes (Wong et al., 2011, Chi et al., 
2006). 
Following the identification of HIF-1 as a key hypoxic response regulator, it was 
found that its overexpression is common in a variety of cancers (Zhong et al., 1999; 
Krieg et al., 2000). Moreover, increased HIF-1 activity has been associated with an 
unfavourable prognosis in most cancers, as it activates genes that play a role in promoting 
the Warburg effect, angiogenesis, cell survival, invasion, and metastasis (Semenza, 2003, 
2010, 2012). Originally, this increase of HIF-1 a protein in cancers was primarily 
attributed to stabilization by environmental hypoxia or genetic mutations (e.g., within 
VHL) in the pathways leading to the destruction of HIF-la (Semenza, 2003). However, it 
has now become clear that most, if not all, human oncogenic viruses directly enhance 
HIF-1 signalling, through the various mechanisms affecting its protein levels and activity 
(Cuninghame et al., 2014). 
1.4 Research Rationale 
Following the discovery of HPV16 as a causative agent of cervical cancer by 
Harald zur Hausen in the early 1980’s, came several reports that HPV16 E6 and E7 in 
combination are necessary and sufficient for the immortalization and transformation of 
primary keratinocytes (Munger et al., 1989, Sedman et al., 1991). However, our 
laboratory recently found that E6 of HPV16 alone is capable of immortalizing primary 
keratinocytes (Niccoli et al., 2012). Furthermore, HPV16 E6 variants differ in their 
ability to immortalize, transform, and migrate keratinocytes in vitro (Richard et al., 2010, 
Niccoli et al., 2012). These HPV16 variants have been named according to the 
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geographical location in which they were first found: European prototype (EP) and 
Asian-American (AA); which differ by only three amino acid substitutions based on six 
single nucleotide polymorphisms (SNPs) in the E6 genetic sequence. While both variants 
are capable of immortalizing primary keratinocytes, the Asian-American variant E6 
(AAE6) is more potent than the European prototype E6 (EPE6) in doing so as suggested 
by a decreased doubling time (Niccoli et al., 2012). Furthermore, only the AAE6 variant 
was able to transform keratinocytes to a malignant phenotype in vitro and had a greater 
ability to induce migration of infected cells (Niccoli et al., 2012). These results are in 
agreement with epidemiological evidence that infection with the AA HPV16 variant is a 
higher risk factor for high-grade cervical intraepithelial neoplasia and progression to 
invasive cervical cancer, as well as an earlier onset of malignancy (Zuna et al., 2009, Xi 
et al., 2007, Berumen et al., 2001). In a three-dimensional organotypic model, AAE6 also 
has an enhanced ability to drive tumourigenesis (Jackson et al., 2014). Elowever, there 
still remains a significant knowledge gap in the current understanding of the molecular 
mechanisms that account for AAE6’s superior ability to enhance the immortalization, 
transformation, and migration in comparison to EPE6, as well as that explaining the 
epidemiological evidence of AAE6 being a greater risk factor for cervical cancer 
progression. 
Accompanying the reports of AAE6’s enhanced immortalization, transformation, 
and migration ability in vitro, is evidence that the Warburg effect and HIF-1 pathway 
may play a role in these carcinogenic properties. Cells that have AAE6 along with E7 
have increased protein levels of metabolic enzymes involved in glycolysis (Richard et al., 
2010) as well as carbonic anhydrase IX (CAIX; Niccoli et al., 2012), all of which are 
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under the regulation of HIF-1 and promote tumourigenesis (Semenza, 2003, Chiche et al., 
2009). AAE6-transduced keratinocytes also exhibit lower protein levels of E-cadherin 
(Niccoli et al., 2012), a key epithelial eell-adhesion protein; the downregulation of which 
is associated with enhanced migratory ability and can be achieved via HIF-1 
transactivating repressors of E-cadherin expression (Onder et al., 2008, Yang et al., 2008, 
Chen et al., 2008). Thus, the Warburg effect and HIF-1 are potential interrelated 
pathways that may explain AAE6’s increased carcinogenic ability and warrants further 
investigation. 
1.5 Hypotheses 
Given the aforementioned evidence for an AAE6-mediated Warburg effect based on 
alterations in the protein level of metabolic enzymes, as well as several additional 
effectors of the HIF-1 pathway, it was hypothesized that: 
1. HA: The HPV16 AAE6 variant induces a greater Warburg effect than EPE6 in 
keratinocytes transduced with E6 alone, and 
2. HA: The induction of the Warburg effect is due to the activation of the HIF-1 
pathway by the HPV16 AAE6 variant 
1.6 Research Aims 
To investigate the presented hypotheses, the following approach was used: 
1. Quantify the relative amounts of glucose consumed and lactate produeed by 
keratinocytes transduced with the HPV16 E6 oncogene of either the Asian- 
American or European Prototype variant. 
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2. Investigate the activation of the HIF-1 pathway in variant-transduced cells: 
a. Determine the relative levels and subcellular localization of HIF-1 a 
b. Determine the transcriptional activity of HIF-1 under both hypoxic and 
normal atmospheric oxygen culture conditions. 
c. Assess gene expression of HIF-1 target genes under both hypoxic and 
normal atmospheric oxygen culture conditions. 
13 
2 MATERIALS AND METHODS 
2.1 Cell Culture 
2.1.1 Cell lines and routine maintenance 
All cell cultures used in this study were maintained in a 37°C incubator with 5% 
CO2, 95% air. For hypoxia incubation, a hypoxic incubator (Coy Lab Products, Grass 
Lake, M.I.) was used with a constant oxygen percentage of 1% achieved by nitrogen gas 
infusion. Media used for each experiment was first equilibrated to 1% O2 conditions by 
placing it in a culture vessel with the lid off in the incubator for a minimum of 60 
minutes. All experiments carried out on cells exposed to hypoxia were done so after 24 
hours of 1 % O2 incubation. 
Two donors of Primary Human Foreskin Keratinocytes (PHFKs, cat. #102-05n) 
were retrovirally transduced with either the EP or AA variant alongside a hemagglutinin 
(HA) tag on the C-terminus on separate occasions by previous lab members Christina 
Richard and Sarah Niccoli (Richard et al., 2009, Niccoli et al., 2012). For simplicity, 
those transduced by CR are denoted as Donor 1 and those of SN, Donor 2. All 
experiments herein were conducted on cells in passages 70 - 80 (Donor 1) and 37-45 
(Donor 2). 
Untransduced PHFKs served as a HPV16 negative control, and HeLa cells 
(HPV18+, ATCC, Manassas, VA, cat. # CCL-2) were used as a HIF-la positive control 
in Western blot procedures. Both transduced and untransduced PHFKs were cultured in 
Serum-Free Keratinocyte Growth Medium (KGM, Cell Applications Inc., San Diego, 
CA, cat. #131-500) that was changed every other day. HeLa cells were cultured in 
Dulbecco’s Minimum Essential Medium (DMEM, Sigma-Aldrich, St. Louis, MO, cat. 
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#D5796) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich, cat. #F6178) 
and 1% antibiotics/antimycotics (Invitrogen, Carlsbad, CA, cat. #15240-062) and media 
was changed every three days. For all cell types, passaging was accomplished via trypsin 
(Fisher Scientific, Mississauga, ON, cat. #SH3023602) that was subsequently neutralized 
by Trypsin Neutralizing Solution (Cell Applications Inc., San Diego, CA, cat. #080-100) 
for HFKs or by supplemented medium for HeLa. HeLa cells were washed with Sterile 
Phosphate Buffer Saline (DPBS, Invitrogen, cat. #14190) prior to the addition of trypsin 
to remove residual medium containing FBS. 
To begin the following passage, -300,000 cells were seeded back for HFKs 
following centrifugation of collected cells to pellet them and remove any residual trypsin 
and neutralizing solution. A 1:20 dilution factor was used to passage HeLa cells without 
centrifugation. 
2.1.2 Cryogenic cell storage 
To ensure a continual supply of cells, vials were prepared during passaging for 
long-term cryogenic storage. Following trypsin neutralization, cells were spun down and 
resuspended in their respective growth medium and counted. The desired amounts of 
cells were then placed in a solution with final volumes of 900 qL of growth medium and 
100 qL of dimethyl sulfoxide (DMSO, Sigma-Aldrich, cat. #34869) in 1.5 mL cryogenic 
storage vials (Fisher Scientific, cat. #03-337-7Y). Cells were frozen to -SO^^C at a 
controlled rate of -l°C/min by placing the tubes in a controlled freezing container (Fisher 
Scientific, cat. #5100-0001). Cryovials were then transferred to liquid nitrogen for long- 
term storage. 
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2.1.3 Removal of cells from cryogenic storage for culture 
To commence culture of cells from cryogenic storage, cryotubes were safely 
removed from liquid nitrogen storage and warmed to room temperature. For HeLa cells, 
the contents of the tube were centrifuged (Beckman, Mississauga, ON, Model #GS-6KR) 
at 25 X g to pellet the cells, allowing for the removal of DMSO from the supernatant. For 
HFKs, the entire 1 mL contents of the tube were added to 10 mL of KGM to dilute 
DMSO to non-toxic concentrations without the application of centrifugation as per 
distributor instructions. Growth medium was changed the following day to ensure the 
removal of residual DMSO. 
2.2 E6 DNA Sequencing 
2.2.1 DNA extraction 
To confirm the retrovirally transduced cells used in this studied harboured the 
proper E6 SNPs, E6 DNA sequencing was performed. Cells were grown to 70 - 80% 
confluence in a 10 cm tissue culture plate and trypsinized to release the cells. Trypsin 
neutralizing solution was added and the eells were spun down at 25 x g. The cell pellet 
was washed with DPBS and spun down a second time before storing at -80^C until all 
samples were collected. DNA was extracted from cell pellets using the DNeasy® Blood 
& Tissue Kit (Qiagen, Valencia, CA., cat. #69504) with isolated DNA eluted from a mini 
spin column in 200 qL of buffer AE. The concentration of DNA was determined using a 
Synergy 4 plate reader (BioTek, Winooski, VT) with a Take-3 microvolume plate. Pure 
DNA samples were accepted as having an A260/280 > 1-8, indicating low levels of protein 
contamination. 
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2.2.2 Polymerase Chain Reaction (PCR) 
PCR was used to amplify the E6 gene from each sample. The applicable volume 
for 100 ng of DNA was added to 2.50 [uL lOX PCR buffer, 1 mM MgCC, 200 pM 
dNTPs, 0.5 pM of both an HPV16 E6 forward (5’-CAATGTTTCAGGACCCACA-3’) 
and reverse (5’-GTTTCTCTACGTGTTCTTGA-3’) primers, 2 units of Taq Polymerase, 
and nuclease free (NF)-dH20 to bring the final reaction volume to 25 pL. A template-free 
control that contained NF-dHzO in lieu of DNA was also ran. The reactions were run 
with the previously optimized parameters of 40 cycles of 1 minute at 94°C for 
denaturation, 1 minute at 56°C for annealing and 2 minutes at 72”C for extension. The 
extension step of cycle 40 was lengthened to 7 minutes and the reaction mixtures were 
cooled to 4®C. 
2.2.3 Agarose Gel Electrophoresis 
Confirmation of E6 amplification was achieved using agarose gel electrophoresis. 
A 1.5% agarose gel was poured by mixing 0.9 g agarose into 60 mL of sterile IX TBE 
buffer (10.8 g Tris Base, 5.5 g boric acid, 2 mM EDTA). The solution was heated and 3 
pL of ethidium bromide was added before pouring the gel. The gel was allowed to 
polymerize for 45 - 60 minutes. A 100 bp DNA ladder (New England Biolabs, Whitby, 
ON, cat. #N0467) was added to the first lane. A 10 pL aliquot of each of the PCR- 
amplified samples was mixed to 2 pL 6X loading dye (Fermentas, Mississauga, ON, cat. 
#R0611) and loaded into separate wells of the agarose gel. The gel was ran for 1 hour at 
100 V and imaged using the BioSpectrum 410 UVP camera and VisionWorks LS 
software on a UV transilluminator. 
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2.2.4 PCR purification 
If non-specific bands were observed by agarose gel electrophoresis, PCR products 
were purified from the agarose gel in order to remove any non-specific bands observed 
that did not correspond with the 448 bp amplicon of E6. The 448 bp amplicons were cut 
out of the gel aided by UV transilluminator to observe the bands. The QIAquick Gel 
Extraction Kit (Qiagen, cat. #28704) was used to extract the DNA from the gel and purify 
the PCR product by washing and elution from a microcentrifuge column with 30 qL of 
Buffer EB. A second gel was run to confirm elimination of non-specific bands from these 
samples. In cases where no non-specific bands by agarose gel electrophoresis were found 
following PCR amplification, the remaining PCR sample was purified using the 
QIAquick PCR purification Kit (Qiagen, cat. #28104) with elution from a 
microcentrifuge column 30 pL buffer EB. Samples were stored at -20°C. 
2.2.5 E6 Sequencing 
To ensure E6 variant DNA had the appropriate SNPs, E6 sequencing was carried 
out at the Paleo-DNA laboratory at Lakehead University. Purified PCR samples were 
diluted to 2 ng/p.L. A 10 qL aliquot of each sample, and each of the forward and reverse 
E6 primers used in PCR were used for sequencing. Forward and reverse reads were 
aligned using BioEdit Sequence Alignment Software v7.1.9. The consensus sequence 
obtained for each sample was matched with the HPV16 E6 reference sequence (Sequence 
ID: NC OOl 526.2) on GenBank to confirm the identity of SNPs for EPE6 and AAE6. 
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2.3 Metabolic profiling 
2.3.1 Glucose uptake assay 
To quantify the rate of glucose uptake, a fluorescently tagged glucose analog, 2- 
deoxy- 2- [(7-nitro-2,l,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG, Cayman 
Chemical, cat. #11046) was used. A 100 mM solution of 2-NBDG was prepared by 
dissolving it in DPBS, and 1 pL of this solution was added to 999 pL of Krebs-Ringer 
Phosphate Buffer (KRPH; 140 mM NaCl, 5 mM KCl, 2.5 mM CaCh, ImM MgS04, 1 
mM KH2PO4, 10 mM HEPES) to make a 100 pM 2-NBDG solution which was then 
added to 80% confluent cells in a 6-well plate. An adjacent control well which did not 
receive 2-NBDG (only 1 mL of KRPH) served as a negative control in each independent 
experiment to determine background fluorescence in the cell lysate not due to 2-NBDG 
uptake. 
Cells were incubated with 2-NBDG for 30 minutes at which time the buffer was 
removed by vacuum and the wells were washed 3 times with 5 mL of DPBS. Cells were 
then lysed in 150 pL of NP40 lysis buffer (1% v/v NP-40, 1% v/v sodium deoxycholate, 
40 mM KCl, 20mM Tris-HCl, pH = 7.4). Cells were scraped from the plate, the lysate 
was collected and then centrifuged at 21,000 x g for 5 minutes at 4°C to pellet the cell 
debris. From the cell lysate, technical duplicates of 50 pL were added to wells of a black- 
coated 96-well plate and fluorescence was read on a BioTek FLxSOO Fluorescence 
microplate reader. Following fluorescence readings, protein amounts were determined 
using the Bradford Assay method. Bradford assays were performed with a 5 pL portion 
of the extracted protein added to 100 pL of Bradford Assay Dye Reagent (BioRad, 
Mississauga, ON, cat. #500-0006) with 400 pL dH20 and chilled on ice for 5 minutes. 
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Following incubation, 300 [iL of the solution was added to a well of a 96-well plate 
(Fisher, cat. #087722c) along with standards of known concentrations (1, 2, 3, 5, 7.5, 10, 
and 20 p,g/|LiL) of Bovine Serum Albumin (BSA, Amresco, Solon, OH, cat. #0332-1000) 
in lysis buffer. Protein concentration was determined using OD measurements at 595 nm 
of standards and samples on a PowerWave XS spectrophotometer (BioTek, Winooski, 
VT). The fluorescence of cell lysates not treated with 2-NBDG was subtracted from those 
that were incubated with 2-NBDG to normalize for the background fluorescence of the 
cell lysates not attributable to 2-NBDG uptake. 
2.3.2 Lactate production assay 
Cells were grown to 50% confluence in 6-well plates, at which time the cells were 
washed three times with 10 mL DPBS and fresh media (10 mL) was given to the cells. 
The cells were allowed to incubate for 24 hours after which media was removed from the 
cells and stored momentarily in 15 mL tubes. Cells were washed once with DPBS and 
cell lysis was performed to obtain protein amounts for normalization. To lyse cells, 150 
pL of RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% SDS, 1% sodium 
deoxycholate, 1% Triton X-100, 5 mM EDTA, 10 mM NaF) with the fresh addition of 10 
mM phenylmethylsulfonyl fluoride (PMSF), a 1:100 dilution of Protease Inhibitor 
Cocktail (Sigma, cat. #P8340), 12.5 pL of activated Na3V04 (Sigma, cat. #6508) was 
added to each plate and incubated on ice for 5 minutes. Cells were scraped and collected 
into microcentrifuge tubes, vortexed, and incubated on ice for an additional 20 minutes. 
The lysates were centrifuged in a pre-chilled (4°C) microcentrifuge (Eppendorf, 
Mississauga, ON, cat. #5414C) at 21,000 x g for 10 minutes to remove cellular debris. 
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The supernatant of the lysate was collected for protein quantification by Bradford assay 
as described in Section 2.3.1. 
To determine the amount of lactate produced by each cell type, the EnzyChrom L- 
Lactate Assay kit (BioAssays Systems, Hayward, CA, cat. #ECLC-100) was used which 
is based on the lactate dehydrogenase (LDH)-mediated oxidation of L-lactate to produce 
NADH. The NADH produced is then used as a cofactor by a second enzyme, diaphorase 
to reduce a tetrazolium compound to formazan. This reaction is accompanied by an 
increase in absorbance at 565 nm, giving an indication of the amount of lactate present in 
a sample. Standards of varying concentrations (0 - 2.0 mM L-Lactate) were prepared in 
unconditioned cell culture medium. To an aliquot of a 1:10 dilution of 20 |aL of media 
from each sample and standard, 80 qL of working reagent was added which contained the 
manufacturers recommended amount of reagents (60 qL of Tris-HCl buffer containing 
Bovine Serum Albumin (BSA), 1 qL of LDH, 1 qL diaphorase, 10 qL of NAD solution 
and 14 qL MTT solution (thiazolyl blue tetrazolium bromide)). The ODo at 565 nm was 
measured at time zero and again 20 minutes after the addition of the working reagent 
(OD2O). The ODo for each sample was subtraeted from its respeetive OD20 and the laetate 
concentration was determined from the standards. 
2.4 Protein detection 
2.4.1 Protein extraction 
Cells were grown in 10 em tissue culture plates until they reached 80 - 90% 
confluence. As a HIT-la positive control, HeLa cells were treated overnight with 150 qM 
of the hypoxic mimetic CoCf. Medium was removed from the cells, which were then 
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washed twice with 5 mL of DPBS and placed on ice. To obtain whole cell lysates 
(WCLs), 250 [iL of cold RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% 
SDS, 1% sodium deoxycholate, 1% Triton X-100, 5 mM EDTA, 10 mM NaF) with the 
fresh addition of 10 mM PMSF, a 1:100 dilution of Protease Inhibitor Cocktail (Sigma, 
cat. #P8340), 12.5 pL of activated Na3V04 (Sigma, cat. #6508) was added to each plate 
and incubated on ice for 5 minutes. Cells were scraped and collected into microcentrifuge 
tubes, vortexed, and incubated on ice for an additional 20 minutes. The lysates were 
centrifuged in a pre-chilled (4°C) microcentrifuge (Eppendorf, Mississauga, ON, cat. 
#5414C) at 21,000 x g for 10 minutes to remove cellular debris. The supernatant of the 
lysate was collected for protein quantification by Bradford assay as described in Section 
4.2.1. 
For separation of nuclear and cytoplasmic fractions, the NE-PER^M Nuclear and 
Cytoplasmic Extraction Kit (ThermoFisher Scientific, Waltham, WA, cat. # 78833) was 
used. Cells were grown as for whole cell lysates and 200 pL of cold CER I buffer was 
added that contained identical protease inhibitor concentrations as described for whole 
cell lysates. Cells were scraped and incubated for 10 minutes on ice, at which point 11 pL 
of CER II was added and the lysate was spun down for 5 minutes at 16,000 x g in a pre- 
chilled (4°C) microcentrifuge. The supernatant that contained the cytoplasmic portion 
was removed and added to a 0.5 mL microcentrifuge tube and stored on ice until use. The 
pelleted material that contained the cell nuclei was washed with 0.5 - 1.0 mL PBS to 
remove any remaining protein from the cytoplasmic portion. The nuclei were then lysed 
in 60 pL of NER with the identical dilution of protease inhibitors as for WCLs. The 
lysate was allowed to incubate on ice for 40 minutes with grinding approximately every 5 
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minutes with a plastic tissue grinder and vortexed every 10 minutes. The lysate was spun 
down for 5 minutes at 16,000 x g in a pre-chilled (4^C) microcentrifuge. Aliquots of 5 qL 
of each subcellular fraction were used for protein estimation by the Bradford method. 
2.4.2 Gel preparation 
To detect relative amounts of proteins of interest in samples, SDS-PAGE 
followed by Western blotting was performed. SDS-PAGE gels were cast by first 
preparing a separating gel mixture in dH20 containing 375 mM Tris-HCl (pH 8.8), 0.1% 
sodium dodecyl sulphate (SDS), 0.06% ammonium persulfate (APS, St. Louis, MO, cat. 
#A9164) and 0.1% TEMED (Sigma St. Louis, MO, cat. #T7024) and 8% acrylamide 
(Bio-Rad, Hercules, CA, cat. #161-0146). This solution was pipetted between two PAGE 
glass plates and allowed to polymerize for 15 minutes, after which a stacking gel 
containing the same components but with 4% acrylamide was added on top of the 
separating gel and a comb placed in the solution to create the wells in which samples 
could then be loaded. The stacking gel was allowed to polymerize for at least 30 minutes. 
2.4.3 SDS-PAGE 
Using known concentrations determined via Bradford assays, the appropriate 
amount of protein was added in a 5:1 dilution to 6X SDS loading buffer (375 nM Tris- 
HCl pH 6.8, 10% SDS, 50% glycerol, 0.03% bromophenol blue) with freshly added 
dithiothreitol (Fisher, cat. #BP1725) to a final concentration of 600 nM and the total 
volume of each sample was calculated. IX SDS was added to samples to bring their 
volume to that of the highest total volume following 6X SDS, to ensure equal volume 
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loading for each sample. Samples were then heated for 5 minutes at 70°C (for HIF-la) or 
95°C, spun down at 21,000 x ^ for 1 minute and loaded to the wells of the prepared SDS- 
PAGE gel that was placed in a IX Running Buffer solution prepared from adding 100 
mL of lOX Running Buffer (30.3 g Tris Base, 144 g glycine, 0.5% SDS in 1 L of dH20) 
to 900 mL of dH20. After addition of the denatured samples to their respective wells of 
the gel, the gel was ran at lOOV until the dye front passed through the stacking gel, at 
which point the voltage was increased to 120V and the gel was ran until the dye front 
reached the bottom of the gel. 
2.4.4 Western Blot 
Following the separation of extracted proteins by SDS-PAGE, the gel was placed 
for 20 minutes in cold IX Transfer Buffer that was prepared from adding 100 mL of lOX 
Transfer Buffer (30.3 Tris Base, 144 g glycine in 1 L of dH20) to 900 mL of dH20. A 
polyvinylidene difluoride (PVDF) membrane was cut to approximately 10 cm x 10 cm 
and soaked in methanol for 5 minutes, followed by a soak in cold transfer buffer for 20 
minutes prior to protein transfer from the gel for 1 hour at 100 V. The membrane was 
then rinsed briefly in lx Tris buffered saline with 0.05% Tween-20 that was prepared 
from adding 100 ml of lOX Tris buffered saline (30.3 g Tris Base, 87.6 g NaCl in 1 L 
dH20 with pH adjusted to 7.5) to 900 mL dH20 and adding 500 |aL of Tween-20 (0.05% 
TBST). The membrane was subsequently blocked for 1 hour in 5% non-fat milk in 0.05% 
TBST. When possible, the membrane was cut in order to allow for concurrent primary 
antibody incubation of several proteins. Primary antibody incubation followed overnight 
with agitation at 4°C with 5% non-fat milk in 0.05% TBST with HIF-la (1:500 dilution. 
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BD Biosciences, Mississauga, ON, cat. #610958), HIF-1(3 (1:1000, BD Biosciences, cat. 
#611078), (3-Actin (1:1000, Santa Cruz Biotechnology, Dallas, TX, cat. #sc-1616), 
Lamin B1 (1:1000, Abeam, Cambridge, MA, cat. #16048), a-Tubulin (1:8000, Sigma, 
cat. #T9026). The following day, the membrane was washed 4x5 minutes in 0.05% 
TBST before the addition of secondary antibody at varying dilutions species specific to 
the primary antibody that was used. Secondary antibody incubation was performed for 1 
hour at room temperature in 0.05% TBST with 5% non-fat milk. The membrane was 
washed again 4x5 minutes in 0.05% TBST before developing the membrane with an 
enhanced chemiluminescence kit (Perkin Elmer Inc., Waltham, MA, cat. 
#NEL100001EA) by mixing 1 mL of each of the two solutions and adding this solution 
to the membrane allowed to incubate for 1 minute with agitation. The membrane was 
imaged with a BioSpectrum 410 UVP camera and VisionWorks LS software using 
exposure times optimized for the specific protein of interest. Densitometry was 
performed using the density analysis tool provided with VisionWorks software using p- 
actin as a loading control for whole cell lysates, lamin B1 for nuclear fractions, and a- 
tubulin for cytoplasmic extracts. 
2.5 Luciferase Assay 
The activity of the HIF-1 transcriptional complex was measured using the 
commercially available Cignal luciferase assay with firefly and Renilla luciferase 
plasmids mixed in a 40:1 ratio (SABiosciences, Frederick, MD, cat. #CCS-007L). The 
luciferase plasmid encodes a HIF-1 responsive construct containing tandem repeats of 
HRE’s joined to a TATA promoter of the firefly luciferase assay. The constitutively 
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expressing Renilla construct encodes the Renilla luciferase gene under the control of a 
CMV promoter to act as an internal control for normalizing transfection efficiency. 
2.5.1 Transfection efficiency 
Prior to determining HIF-1 activity in E6-transduced keratinocytes, optimization 
of the transfection parameters was carried out. A GFP positive control plasmid that 
constitutively expresses GFP is included with the firefly and Renilla plasmids that allows 
for visual confirmation of transfection by fluorescent microscopy with filters having an 
excitation of 470 nm and an emission of 515 nm. A qualitative assessment of transfection 
efficiency was carried out using several transfection reagents including HiPerfect 
(Qiagen, cat. #301707), FuGene 6 (Promega, Madison, WL, cat. #E2692), Mims 
Trans\T-2020 (Mims, Madison, WI, cat. #MIR5404), TranslT-LT\ (Mims, cat. 
#MIR2304, and TransYY-X2 (Mims, cat. #MIR6003). Variable amounts of plasmid and 
transfection reagent in the recommended ranges for each individual reagent were used to 
determine the optimal conditions for transfection of the luciferase plasmids. 
2.6.2 Luciferase reporter assay for HIF-1 activity 
Once the optimal parameters for transfection of the firefly and Renilla plasmids 
were determined, analysis of the specific activity of HIF-1 in E6-transduced cells was 
performed under both normoxic and hypoxic conditions using a reverse transfection 
method. To prepare transfection complexes, a stock solution was mixed that had 
sufficient volume for 7 transfections, for 3 technical replications per experiment of both 
EPE6 and AAE6-transduced cells with an additional transfection volume to account for 
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pipetting errors. To do this, 341.6 pL of KGM was mixed with 1.4 pL of Mims TransYI- 
2020 and 7 pL of plasmid mixture. Of this, 50 pL was added to individual wells of a 
white coated Corning® 96-well clear bottom plate (VWR, Radnor, PA., cat. #29444- 
010). Cells were trypsinized from T75 flasks when at 80 - 90% confluence and diluted to 
a concentration of 4.0x10^ cells/mL in KGM. From this, 50 pL of cell suspension was 
added to wells harbouring 50 pL of the transfection complex to give a final volume of 
100 pL and 2.0x10"^ cells. Cells were allowed to incubate for 48 hours, at which point 75 
pL of fresh KGM was given and the cells incubated either under normoxia or hypoxia for 
an additional 24 hours. 
To measure the amount of firefly or Renilla luciferase activity the Dual-Glo® 
Luciferase Assay System (Promega, cat. #E2920) was used. Upon receipt, the entire 
contents of the Dual-Glo® Luciferase Buffer was added to the bottle of lyophilized Dual- 
Glo® Luciferase Substrate to make the Dual-Glo® Luciferase Reagent. The Dual-Glo® 
Luciferase Reagent contains beetle luciferin, a substrate for recombinant firefly luciferase 
that is not produced endogenously by mammalian cells and produces light when 
converted to oxyluciferin (Figure 4A). Thus, the amount of light produced by this 
reaction gives an indirect measurement of the amount of firefly luciferase produced by 
HIF-1. Immediately prior to firefly luciferase measurement, the media was removed from 
the cells and 75 pL DPBS was added to wells because Phenol Red in the media interferes 
with the luciferase signal. An equal volume of Dual-Glo® Luciferase Reagent to that of 
the DPBS in the wells (75 pL) was added with a multichannel pipette and mixed 
thoroughly by pipetting. The mixture was incubated at room temperature for 15 minutes, 
and the luminescence was read in a BioTek FLx800 Fluorescence microplate reader to 
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determine the amount of firefly luciferase activity. To measure activity of the 
constitutively expressed Renilla luciferase as a control for transfection efficiency, Dual- 
Glo® Stop & Glo® Substrate was diluted 1:100 in Dual-Glo® Stop & Glo® Buffer. Of 
this, a volume equivalent to the original amount of DPBS present in the wells (75 (LIL) 
was added to the wells. Dual-Glo® Stop & Glo® Reagent contains coelenterazine, a 
substrate for Renilla luciferase that is converted to coelenteramide with the production of 
light (Figure 4B). Upon addition of the Dual-Glo® Stop & Glo® Reagent, the solution 
was allowed to incubate again at room temperature for 15 minutes, at which point the 
Renilla luminescence was measured. As a representation of the relative HIF-1 activity 
present in each cell type, a ^hQ^\y/Renilla luminescence ratio was determined. 
2.6 Gene expression analysis 
2.6.1 Sample preparation, RNA Extraction and Quality assessments 
Cells were grown in T25 flasks to 80 - 90% confluence, and harvested with 
trypsinization and placed in a 15 mL tube. The cell suspension was spun at 300 x g to 
form a cell pellet that was then washed with 5 mL DPBS and spun down a second time. 
The DPBS supernatant was aspirated off and the cell pellet was stored at -80°C until all 
samples were collected. RNA was extracted from cell pellets using the Arcturus PicoPure 
RNA Isolation Kit (Applied Biosystems, Carlsbad, CA, cat. #KIT0204) with 30 pL of 
elution buffer following DNAse removal using the RNAse-free DNAse set (Qiagen, cat. 
# 79254). Aliquots were made at the time of isolation for the purposes of determining 
RNA integrity, concentration, and purity. The integrity and concentration of the RNA 
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Figure 4. Reactions catalyzed by firefly and Renilla luciferase. (A) In the Dual-Glo® 
Luciferase Reagent, beetle luciferin is oxidized by firefly luciferase to produce 
oxyluciferin and light in the presence of Mg . (B) Colenterazine in the Dual-Glo® Stop 
& Glo® Reagent is oxidized to coelenteramide by Renilla luciferase to produce light. 
Image acquired from datasheet for dual-glo® luciferase assay system (Promega cat. 
#E2920). 
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was measured using the BioRad Experion Automated Electrophoresis system with the 
StdSens Analysis Kit (BioRad, Hercules CA, cat. # 700-7111). RNA quality indicator 
(RQI) values were obtained based on the 28S:18S ratio, and only those samples with an 
RQI >7.0 were deemed acceptable for further analysis. The RNA purity was determined 
by an A260/A280 absorbance ratio using a Synergy 4 plate reader (BioTek, Winooski, VT) 
with a Take-3 microvolume plate. Pure RNA samples, were accepted as having an 
A260/280 > E9, indicating low levels of protein contamination. 
2.6.2 Conversion of RNA to cDNA 
Isolated RNA was converted to complementary DNA (cDNA) using the High 
Capacity cDNA Archive kit (Applied Biosystems, cat. #4368814). Final reaction 
volumes were 60 pL containing 6 pL RT buffer, 6 pL primers, 2.4 pL dNTPs, 3 pL 
Multiscribe enzyme solution, 12.6 pL nuclease-free water, and 30 pL of sample RNA 
carried out in a nuclease-free 0.5 pL PCR tube. A template-free control that contained 
only 30 pL in lieu of sample RNA was also ran. Samples were placed in a 2720 
Thermocycler (Applied Biosystems) and run for 10 minutes at 25”C, 120 minutes at 
37^C, 5 minutes at 85°C, and cooled to 4^C. 
2.6.3 Real-Time Polymerase Chain Reaction 
To quantify relative mRNA levels for a transcript of interest from reverse 
transcribed RNA, real-time polymerase chain reaction (RT-qPCR) was performed using a 
7500 Real-Time PCR System (Applied Biosystems). Reaction mixtures were prepared 
again in 0.5 pL nuclease-free PCR tubes containing 150 ng of cDNA, 45 pL TaqMan 
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Gene Expression Master Mix (Applied Biosystems, cat. #4304437) and 4.5 \iL TaqMan 
Gene Expression assay (Applied Biosystems, Table 1). To bring the final volume of the 
mix up to 90 |iL, nuclease-free water was added. Technical triplicates were performed as 
25 p,L fractions of the reaction mixture were added to 3 wells of a transparent MicroAmp 
Optical 96-Well Reaction Plate (Applied Biosystems, cat. # 4306737). The negative 
control reaction from cDNA preparation was also prepared for each plate that did not 
contain any cDNA but only nuclease-free water, as well as a positive tumour sample 
control to assess inter-plate variability. The cycle threshold (Ct) was obtained for each 
transcript of interest and the Livak method (Livak and Schmittgen, 2001) was used to 
determine mRNA expression relative to the reference gene HPRTl in each sample. 
HPRTl was chosen as a reference gene based on previous studies that found it to remain 
unchanged in cells infected with HPV (DeCarlo, et al., 2008). 
2.7 Statistical Analysis 
All statistical analyses, as well as the production of figures were done using the 
open source programming language R (v3.1.0), in the RStudio integrated development 
environment (IDE). Data were tested for the parametric assumptions of normality and 
homogeneity of variance subjectively by histograms and box plots, respectively, and as 
well by the objective statistical tests, Shapiro-Wilks normality test and Bartlett test, 
respectively. Significance was set a priori as a = 0.05. For statistical testing of 
experiments with two levels of one independent variable (IV), Student’s t-test was used. 
Multi-way ANOVAs were used for experiments with more than two levels in I Vs. Error 
bars above and below the arithmetic mean represent the standard deviation in all graphs. 
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3.1 Characterization of E6 variants used in this study 
3.1.1 Confirmation of variant specific SNPs 
To study the effects of E6 variants on glucose metabolism, a two-donor approach 
was exploited in this study to consolidate the effects of E6 variants regardless of genetic 
background of the host. These two donors were used on separate occasions previously to 
study the differential ability of E6 variants to induce immortalization, transformation and 
migration of human keratinocytes (Richard et ah, 2010, Niccoli et ah, 2012). Prior to 
carrying out an investigation of E6 variant’s effect on metabolism, E6 DNA that was 
previously retrovirally transduced into PHFKs (Donor One) was sequenced. Another 
member of the lab recently sequenced Donor Two and the correct SNPs for each variant 
were confirmed (Togtema, 2013). Sanger sequencing on PCR amplified E6 DNA was 
performed at Lakehead University’s Paleo-DNA Laboratory and confirmed the 
appropriate SNPs present in cells harbouring each variant (Table 1, Appendix Figure A1 
& A2). 
3.1.2 Relative E6 expression is equal betM^een variants of each donor 
To ensure that investigation into metabolic alterations by E6 variants was not due 
to varying levels of E6 gene expression, RT-qPCR was performed on E6 mRNA from 
cells harbouring the confirmed E6 variant. E6 expression from each donor and for each 
variant was similar (Figure 5). Thus, any effects of these variants on metabolism are not 
due to differences in E6 expression levels. 
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Table 2. Detected SNPs in EPE6 and AAE6 from Donor One. 




1) base 145, G->T 
2) base 286, T -> A 
3) base 289, A -> G 
4) base 335, C -> T 
5) base 350, T -> G 
6) base 532, A -> G 
0 
1) base 145, G -> T 
2) base 286, T -> A 
3) base 289, A -> G 
4) base 335, C -> T 
5) base 350, T -> G 
6) Not detected'^ 
^In reference to sequence ID NC_001526.2 
^This silent SNP is located in a region corresponding to the reverse E6 primer sequence and outside the range 
of the forward primer 
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Figure 5. E6 expression was similar between variants from each donor. E6 
expression was analyzed by RT-qPCR and E6 mRNA levels were similar between 
variants from each Donor. No significant difference in E6 expression was detected 
between donors (p = 0.830) or variants {p = 0.816). An interaction effect (p = 0.636) was 
not found (Two-way ANOVA). The means +/- standard deviation are presented, /? = 6. 
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3.2 Metabolic phenotype of cells transduced with E6 variants 
Previous work by our group has documented some of the differential effects on 
carcinogenesis by HPV16 E6 variants (Lichtig et ah, 2006, Richard et al., 2010, Niccoli 
et al., 2012, Jackson et ah, 2014). Of particular interest has been understanding the 
biology of the AA variant and how this may offer a malignant advantage over its EP 
counterpart. Protein analysis using 2D gel electrophoresis has found that, in the company 
of E7, the AAE6 variant led to alterations in the levels of several enzymes (upregulation 
of GAPDH, PKM2 and downregulation of IDHl & 2, malate dehydrogenase) involved in 
glucose metabolism (Richard et al., 2010). These observations, alongside the 
epidemiological evidence of the HPV16 AA variant being a greater risk factor for 
invasion, lead to the hypothesis that AAE6 increased the Warburg effect since aerobic 
glycolysis promotes invasion (Gatenby et al., 2006, Lu et al., 2014). Thus, to determine 
whether AAE6 causes a metabolic shift reminiscent of a Warburg effect, glucose 
consumption and lactate production were measured in PHFKs transduced with each 
variant in two separate donors. 
3.2.1 Keratinocytes immortalized by AAE6 enhance glucose consumption in comparison 
to that of EPE6 
The consumption of glucose is often enhanced by cancer cells to ensure a 
continual supply of carbon needed for proliferation, while also increasing the amount of 
energy that can be obtained through a Warburg phenotype. To determine whether or not 
enhancement of glucose influx accompanied keratinocytes harbouring AAE6’s 
production of lactate, a glucose analog having a fluorescent tag at the 2’-position was 
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used (2-NBDG). Cells were incubated with 2-NBDG, lysed, and the fluorescence was 
measured to determine if there was a difference in the ability of E6 variants to take up 
glucose. There was a significant increase in the normalized fluorescence of cell lysates of 
AAE6-transduced keratinocytes compared to EPE6 {p = 0.002, Figure 6). No significant 
difference between the donors {p = 0.206) was found. The enhanced glucose consumption 
suggests the AAE6 variant induces a Warburg-type metabolism upon infection of host 
keratinocytes. 
3.2.2 Lactate production is increased by keratinocytes immortalized by AAE6 in 
comparison to EPE6 
Using a tetrazolium-based assay on the growth media collected from each cell 
type, the amount of L-Lactate produced was determined. In this assay, LDHB is used to 
convert L-lactate that has been excreted into pyruvate, a reaction that produces NADH. 
The addition of diaphorase then uses the production of NADH to measure the conversion 
of tetrazolium to formazan, accompanied by a quantifiable colour change. The amount of 
lactate in the supernatant was significantly higher (~1.37-fold for Donor One, ~1.59-fold 
in Donor Two) in cells transduced with the AAE6 variant in comparison to EPE6 in both 
donors ip = 2.44x10’^, Figure 7). No significant difference between the donors ip = 
0.657) was found. These results suggest that upon infection with the AAE6 variant, 
metabolism is altered to produce more lactate, a hallmark of the Warburg effect that 
promotes invasion and metastasis (Gatenby et al., 2006). Collectively, the glucose 
consumption and lactate production increase in AAE6-transduced keratinocytes, 
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Figure 6. Glucose Consumption of keratinocytes transduced with E6 variants. 
AAE6-transduced keratinocytes take up significantly more 2-NBDG in comparison to 
EPE6-transduced keratinocytes (p = 0.002, Two-way ANOVA, n = 3). No significant 
donor (p = 0.1142) or interaction (p = 0.5920) effects were found. The fluorescence of 
cell lysates from those treated with 2-NBDG was normalized to protein by Bradford 
assay and subtracted from that of a parallel well of cells not given 2-NBDG. 
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Figure 7. Lactate production of keratinocytes transduced with E6 variants. AAE6- 
transduced keratinocytes metabolize significantly more lactate in comparison to EPE6- 
transduced cells {p = 2.44x10'^, Two-way ANOVA, n = 6). No significant donor {p = 
0.657) or interaction {p = 0.250) effects were found. Lactate produced was normalized to 
the amount of protein by Bradford assay. 
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3.3 AAE6-transduced PHFKs increase HIF-la protein levels 
The metabolic phenotype of a Warburg effect can be brought about by several 
molecular mechanisms. These include, but are not limited to, alterations in pyruvate 
kinase isoform (PKMl vs. PKM2) expression and activity, Akt stimulating the 
translocation of glucose transporters to the cell surface, dysfunction of TCA cycle 
enzymes, and the transcriptional enhancement of metabolic genes by c-myc or HIF-1 
(Cairns et ah, 2011). Previous results by our group have alluded to the possibility that 
HIF-1 transcriptional activity is enhanced by AAE6 based on evidence that protein levels 
of HlF-1 target genes (or their effectors) are altered in AAE6-transduced keratinocytes 
(Richard et al., 2010, Niccoli et al., 2012). Furthermore, overexpression of HlF-la is 
common in cancer (Zhong et al., 1999) and is associated with an increase in invasive 
potential and a poor prognosis (Semenza et al., 2003), including in cervical cancer 
(Bimer et al., 2000, Huang et al., 2014). The increases in protein levels of HlF-1 targets, 
coupled with a metabolic phenotype reminiscent of the Warburg effect have provided 
strong evidence for HIF-1 activity to be enhanced by AAE6. Thus, the HIF-1 pathway 
was investigated in the context of these two E6 variants. Investigation into the HIF-1 
pathway was carried out in Donor One only as both donors showed a similar metabolic 
phenotype, and these were the cells used previously to highlight AAE6’s enhanced 
transformation potential (Niccoli et al., 2012). 
3.3.1 Whole cell lysates show HIF-la is enhanced in AAE6-transduced keratinocytes 
Induction of HIF-1 activity can be achieved by several mechanisms that act to 
induce HIF-la protein levels, while HIF-1 p is constitutively expressed (Semenza, 2010). 
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Therefore, Western blot analysis was used to determine if HIF-la protein levels differed 
in the variant-transduced PHFKs. A positive control of HeLa cells treated with C0CI2 was 
used as a HIF-la marker in Western blots to ensure technical parameters allowed for the 
detection of HIF-la. Under normoxic conditions, densitometry analysis revealed a 
significant increase in the relative protein levels of HIF-la normalized to the loading 
control, (3-Actin, in AAE6-transduced keratinocytes in comparison to untransduced 
PHFKs (~3.9-fold,= 0.022) and EPE6-transduced keratinocytes (-2.7-fold, p = 0.042, 
Figure 7). No significant difference was found between EPE6-transduced keratinocytes 
and untransduced PHFKs {p = 0.848). Thus, in the presence of the AAE6 variant, HIF-la 
accumulation in keratinocytes is seen compared to EPE6 and represents a potential novel 
function of this variant that may contribute to its increased risk for progression to 
invasive cervical cancer. 
3.3.2 The nuclear pool of HIF-la is enriched by AAE6 in comparison to EPE6 
Following the translation of HIF-la mRNA to protein in the cytoplasm, it is readily 
degraded under normoxic conditions when a completely active HIF-la-degradation 
pathway is present. If HIF-la is not sufficiently degraded due to environmental hypoxia, 
inactivation of any one of the several regulators involved its degradation (i.e., prolyl 
hydroxylases or the von Hippel Lindau tumour suppressor protein), or an increase in the 
rate of HIF-la mRNA translation, it may translocate to the nucleus to dimerize with HIF- 
1 p and become transcriptionally active. 






Figure 8. Western blot analysis of HIF-la protein levels in keratinocytes. (A) 
Representative blot of three independent experiments showing HIF-la increased in 
comparison to untransduced PHFKs and EPE6-transduced keratinocytes. Cobalt chloride 
treated (24 hour, 150 pM) HeLa cells served as a positive control of HIF-la. (B) 
Densitometry analysis of relative levels of HIF-la normalized to the housekeeping 
protein |3-Actin. AAE6 cells show significantly more HIF-la in comparison to EPE6 
cells ip = 0.042) and untransduced PHFKs {p = 0.022, Tukey-HSD test, n = 3). 
PHFK EPE6 AAE6 (^oCy 
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transport of several proteins with an NLS sequence across the nuclear membrane 
(Depping et al., 2008). Thus, to investigate whether or not the differences in HIF-la 
protein levels were also found in the nucleus, Western blotting on subcellular fractions 
was performed. The majority of HIF-la detected was located in the nucleus and little (in 
some trials, none) was detectable in the cytoplasm (Figure 8A). Densitometry revealed a 
significant increase {p = 0.031) in the amount of HIF-la detected in AAE6 cells in the 
nucleus but not in the cytoplasm {p = 0.837), relative to their respective subcellular 
loading controls (Figure 8B). Therefore, the HIF-la detected in both AAE6 and EPE6- 
transduced keratinocytes resides primarily in the nucleus, where it may dimerize with its 
transcriptional co-activators and proceed to transactivate its target genes. 
3.4 Luciferase reporter assay for HlF-1 reveals HlF-1 transcriptional activity is 
enhanced under hypoxia in AAE6-transduced keratinocytes. 
Upon translocation to the nucleus, HIF-la can dimerize with HIF-1(3, followed by 
transcription complex formation with p300/CBP (Semenza, 2003). Subsequent binding of 
the HIF-la/HIF-l|3/p300 transcription factor complex to HREs in the promoter sequence 
of target genes results in augmentation of their transcription. To determine whether the 
enhanced HIF-la protein level present in AAE6-transduced keratinocytes causes an 
increase in the transcriptional activity of HIF-1, a luciferase reporter assay was used. A 
plasmid encoding the firefly luciferase gene sequence under the control of a HIF-1- 
inducible promoter was cotransfected with a constitutively active Renilla luciferase gene 
for transfection normalization. Enzymatic activity of each luciferase is then quantified to 
determine the ability of HIF-1 to induce transcription of HIF-1-responsive genes. 
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Figure 9. Western blot analysis of subcellular fractions of HIF-la protein. (A) 
Representative blot of three independent experiments showing HIF-la nuclear pool 
increased in AAE6-transduced keratinocytes. A whole cell lysate of cobalt chloride 
treated (24 hour, 150 pM) HeLa cells served as a positive control of HIF-la. (B) 
Densitometry analysis of relative levels of HIF-la normalized to subcellular 
housekeeping proteins. AAE6 cells show significantly more HIF-la in comparison to 
EPE6 cells in nuclear (p = 0.031) but not in cytoplasmic (p = 0.837) fractions (Student’s 
t-test, n = 3). 
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3.4.1 GFP transfection optimization 
Prior to HIF-1 activity determination, confirmation of transfection had to be 
carried out. To do this, a constitutively active GFP plasmid included with the CignaF^ 
firefly and Renilla plasmids was used. Several transfection reagents and variable amounts 
of plasmid were used to qualitatively determine the optimal amounts of each for a 
successful transfection. Several commercially available transfection reagents were tried 
(Fugene 6, FliPerfect, Attractene, Mirus2020 and Mims X2) with variable amounts of 
transfection reagent and DNA. Finally, both Mims 2020 and Mims X2 transfection 
reagents similarly gave the best transfection efficiency (-10% for both EPE6 and AAE6) 
with the lowest cytotoxicity using a volume of 0.20 pL/100 pL cell suspension and 100 
ng of plasmid (Figure 10). No increase in transfection efficiency was observed when 
plasmid amount increased (data not shown). 
3.4.2 HIF-1 activity is enhanced under hypoxia in AAE6-transduced keratinocytes in 
comparison to EPE6-transduced keratinocytes 
Following the transfection optimiazation, luciferase assays were performed under 
both ambient oxygen and hypoxia. This was done to determine if ElIF-1 activity was 
altered between variants under the normoxic conditions where a difference in HIF-1 a 
protein was detected, as well as the hypoxic environment found in many tumours (Wilson 
& Hay, 2011). No difference in firefly/Renilla luciferase activity ratio between cell types 
was observed under normoxia {p = 0.604, Figure 11). However, a significant increase 
was observed in the ratio for AAE6-transduced keratinocytes in comparison to EPE6 










Cignal™ GFP Phase 
Figure 10. Confirmation of CignaF^ reporter plasmid transfection. Representative 
image of Cignal™ GFP positive control plasmid, that was used to determine the optimal 
transfection reagent, volume, and amount of DNA to use to transfect luciferase reporter 
plasmids. Shown here, Mims reagents gave the best transfection efficiency (-10% in both 
cell types) with the lowest cytotoxicity. 
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Figure 11. AAE6 induces HRE-responsive Luciferase activity to a greater degree 
under hypoxia. HRE Luciferase activity (normalized to Renilla) was significantly 
increased under hypoxia for both EPE6 {p = 4.05x10'"^) and AAE6 {p = 7.5x10'^). 
Luciferase activity was significantly greater in AAE6 under hypoxia in comparison to 
EPE6 ip = 0.017, Tukey HSD). The means +/- standard deviation are shown, « = 3. 
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3.5 Transactivation of HIF-1 target genes in variant transduced keratinocytes 
It is has been estimated that HIF-1 activates the transcription of nearly 100 genes 
involved in metabolism, angiogenesis, cell survival, and invasion (Semenza, 2003). With 
evidence that HIF-1 protein levels and activity under hypoxia are enhanced in AAE6, 
whether the transactivation of HIF-1 target genes was responsible for the observation of 
an enhanced Warburg effect by AAE6 was investigated. Using RT-qPCR, the relative 
expression of HIF-1 target genes involved in this metabolic shift including glucose 
transporter 1 (GLUTl), Hexokinase II (HK2), lactate dehydrogenase A (LDHA) and 
pyruvate dehydrogenase kinase 1 (PDKl) were assayed. The expression of VEGF-A was 
also examined as a classical HIF-1 target gene responsible for tumour angiogenesis. 
Again, gene expression was studied both under normoxia and hypoxia as promoter 
activity analysis revealed a significant increase in HIF-1 activity only under hypoxic 
conditions. 
As stated previously, an increase in the rate of glucose consumption is a hallmark 
of most proliferating cells. The facilitative glucose transporter proteins, GLUTl - 9, 
control the increased uptake of glucose in cancer cells (Levine 8L Puzio-Kuter, 2010). 
HIF-1 activates the transcription of GLUTl and GLUT3 in several cancers to facilitate 
the increased requirement for glucose for proliferation and cell survival (Semenza, 2010). 
Given that AAE6 induced an increase in glucose consumption, GLUTl expression was 
measured both under ambient air conditions (normoxia) and hypoxia (Figure 12A). Two- 
way ANOVA revealed a significant increase in GLUTl expression for AAE6 {p = 0.022) 
and under hypoxia {p = 5.26x10'^) as well as an interaction effect {p = 0.006) indicating a 
differential response of the variants between the two oxygen levels tested. Post-hoc 
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analysis revealed a significant increase in GLUTl expression under hypoxia in AAE6 
keratinocytes compared to EPE6 {p = 0.008). The hypoxic induction of GLUTl 
expression was ~1.9-fold higher in AAE6 compared to EPE6 (Figure 12B). 
Upon transport into the cell by facilitated glucose transport, glucose is 
phosphorylated at the 6’-position by hexokinase I, II, or III. Hexokinase I and II are target 
genes of HIF-1 and HK2 upregulation is closely associated with a Warburg metabolism 
(Mathupala et al., 2009), so it represented an interesting HIF-1 target gene to investigate 
in the context of the E6 variants. Again, the expression of HK2 was analyzed both under 
normoxia and hypoxia (Figure 13 A). In this case, only a significant difference was found 
between hypoxia and normoxia {p = 3.68x10'^) with no difference between the variants {p 
= 0.200) or interaction effect {p = 0.636). The hypoxic induction of HK2 expression did 
not yield a significant difference between the variants {p = 0.728, Figure 13B). 
The production of lactate is one of the key features of the Warburg effect. The 
synthesis of lactate from pyruvate is catalyzed by LDHA and thus represents an 
additional interesting HIF-1 target with regards to the Warburg effect. Surprisingly, 
LDHA expression was lower in AAE6 than in EPE6 {p = 0.030), along with the expected 
significant main effect of oxygen levels {p = 7.51x10'^). However, no interaction effect {p 
= 0.480) was found, indicating that the intrinsic levels of LDHA gene expression are 
higher in EP (Figure 14A). However, the extent of hypoxic induction of LDHA mRNA 
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Figure 12. Relative GLUTl mRNA levels in E6-transduced keratinocytes under 
normoxic and hypoxic conditions. (A) GLUTl expression was significantly higher 
under hypoxia in comparison to normoxia for both EPE6 {p = 0.005) and AAE6 (p = 
S.OOxlO’"^). AAE6 showed significantly higher expression of GLUTl in comparison to EP 
under hypoxia (p = 0.008, Two-Way ANOVA with Tukey EiSD post-hoc). (B) The 
hypoxic response of GLUTl expression in comparison to normoxia was greater in AAE6 
cells than EPE6 cells (p = 0.011, Student’s t-test). The means +/- standard deviation are 











Figure 13. Relative HK2 mRNA levels in E6-transduced keratinocytes under 
normoxic and hypoxic conditions. (A) HK2 expression was significantly higher under 
hypoxia (p = 3.68x10'^) with no variant differences {p = 0.200) or interaction (p = 0.636, 
Two-Way ANOVA) effect. (B) The hypoxic response of HK2 expression in comparison 
to normoxia was similar between variants (p = 0.728). The means +/- standard deviation 
are presented, = 3. 
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Figure 14. Relative LDHA mRNA levelsin E6-transduced keratinocytes under 
normoxie and hypoxie conditions. (A) LDHA expression was significantly higher under 
hypoxia {p = 7.51x10'^) and in EPE6 {p = 0.030) but no interaction effect {p = 0.480, 
Two-Way ANOVA) was found. (B) The hypoxic induction of LDHA expression was 
higher in AAE6 but not significantly {p = 0.264). The means +/- standard deviation are 
presented, n = 3. 
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In addition to LDHA, PDKl also regulates the metabolic fate of pyruvate and 
increases lactate production. PDKl phosphorylates pyruvate dehydrogenase (PDH), 
inhibiting its ability to metabolize pyruvate into acetyl Co-A. An increase in PDKl 
expression is recognized as a HIF-1-regulated metabolic shift required for adaptation to 
hypoxia (Kim et al., 2006). PDKl expression was slightly increased in AAE6, although 
this was not statistically significant {p = 0.177, Figure 15A). Again, hypoxia significantly 
increased {p = 3.58x10'^) PDKl expression with no interaction effect {p = 0.323). The 
hypoxic induction of was higher in AAE6, although not significantly {p = 0.264, Figure 
15B). 
Along with genes involved in metabolism, HIF-1 also transactivates the 
expression of proangiogenic genes. Vascular endothelial growth factor-A (VEGF)-A is 
an HIF-1 target that interacts with its cognate receptor, VEGFR that is expressed solely 
on endothelial cells and stimulates their proliferation, forming new blood vessels (Lee et 
al., 2004). Induction of angiogenesis via HIF-1 is an integral part of a tumour’s ability to 
adapt to the intratumoural hypoxia that accompanies cell proliferation. If tumours do not 
have access to a blood supply, sufficient nutrients cannot be obtained for sustained 
proliferation and survival, so it is not surprising that inhibition of angiogenesis is 
associated with a decrease in the rate of tumour growth and progression (reviewed in 
Liao & Johnson, 2007). Therefore, VEGF-A expression was examined in the context of 
E6 variants under hypoxia and normoxia. Two-way ANOVA again revealed VEGF-A 
expression was significantly higher under hypoxia {p = 6.98x10'^) but no difference 
between variants was found {p = 0.098, Figure 16A). While a significant interaction 













Figure 15. Relative PDKl mRNA levels in E6-transduced keratinocytes under 
normoxie and hypoxic conditions. (A) PDKl expression was only significantly higher 
under hypoxia (p = 3.58x10’^) with no significant variant (p = 0.177) or interaction effect 
(p = 0.323, Two-Way ANOVA) (B) The hypoxic induction of PDKl expression was not 
significantly greater in AAE6 cells than EPE6 cells (p = 0.3959, Student’s t-test). The 









Figure 16. Relative VEGF-A mRNA levels in E6-transduced keratinocytes under 
normoxic and hypoxic conditions. (A) VEGF-A expression in Donor One was greater 
g 
under hypoxia {p = 6.98x10' ) with difference between variants {p = 0.098), although an 
interaction effect was found {p = 0.043, Two-Way ANOVA). However, Tukey HSD 
post-hoc analysis revealed no significant differences between cell types at the same 
oxygen level. (B) The hypoxic induction of VEGF-A expression was significantly greater 
in AAE6 in comparison to EPE6 {p ^ 0.002). The means +/- standard deviation are 
shown, « = 3. 
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significant differences between variants at the same oxygen level. However, the induction 
of VEGF-A expression under hypoxia (Figure 16B) was significantly higher in AAE6 {p 
= 0.006). 
4 DISCUSSION 
4.1 The AAE6 variant of HPV16 enhances the Warburg effect in transduced 
keratinocytes 
In this study, the glucose metabolism of cells that express two common variants 
with different risk factors for invasive cervical cancer was investigated. An increase in 
glucose consumption and subsequent production of lactate are hallmarks of cancer cells 
(Hanahan & Weinberg, 2011). Furthermore, the alteration of glucose metabolism is a 
unifying theme of oncogenic viruses (Noch & Khalili, 2012). In this study, a metabolic 
shift was found in AAE6-transduced keratinocytes in accordance with a Warburg effect 
as both glucose consumption and lactate production were enhanced by AAE6 over EPE6. 
Therefore, the alternative hypothesis put forth at the onset of this study that there is a 
difference in the Warburg effect between host cells with each variant is valid. These 
findings have several implications that may help to explain the differential ability of these 
two common HPV16 variants in tumour progression. 
It has been recently postulated that a Warburg metabolism supports increased 
proliferation as it provides increased carbon for anabolic processes without the 
production of growth inhibitory ROS typical of oxidative phosphorylation (Vander 
Heiden, 2009). The results reported herein support this hypothesis as AAE6 displays the 
metabolic phenotype of a Warburg effect, as well as decreases the doubling time when 
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transduced into PHFKs compared to EPE6 (Richard et al., 2010, Niccoli et al., 2012). In 
addition to enhancing proliferation, the Warburg effect may contribute to AAE6’s ability 
to promote malignant transformation (the process by which normal cells acquire the 
properties of cancer) of immortalized keratinocytes (Niccoli et al., 2012). While it is well 
understood that the Warburg effect by itself is not sufficient to cause transformation, it 
does appear to be a requirement for transformation to occur (Kim & Dang, 2006). 
Furthermore, aerobic glycolysis also contributes to extracellular acidification, a condition 
promoting clonal selection (selection for cancer cells over their non-transformed 
counterparts), local invasion, and tumour progression (Gatenby et al., 2006, Estrella et al, 
2013). With evidence here for enhanced lactate production in AAE6 transduced cells, it is 
possible that this altered metabolism may contribute to AA variants’ increased risk for 
progression to high grade intraepithelial neoplasia (Xi et al., 2007) and invasive cervical 
cancer (Berumen et al., 2001). 
4.2 Enhanced levels of HIF-1 (X protein in AAE6-transduced keratinocytes 
Enhanced glucose uptake and laetate production are two common characteristics 
of aggressive cancers that may arise by several mechanisms that act to induce the 
transcription of genes involved in metabolism, or by altering enzyme activity (Cairns et 
al., 2011). HIF-1 protein levels and activity are commonly enhanced in cancers through 
various mechanisms to transcriptionally increase a wide array of genes involved in cancer 
progression, including those responsible for the Warburg effect (Semenza et al., 2010). 
Thus, HIF-1 represented a plausible explanation for the enhanced Warburg effect 
observed in AAE6-transduced keratinocytes based on previous findings that the protein 
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levels of HIF-1 targets (GAPDH, PKM2, CA9) or proteins influenced by HIF-1 target 
genes (E-cadherin) differ between AAE6- and EPE6-transduced keratinocytes (Richard 
et al., 2010, Niccoli et al., 2012). In accordance with this hypothesis, HIF-1 a protein 
levels were enhanced in AAE6-transduced keratinocytes. Furthermore, control of the 
nuclear localization of several transcription factors is an important step in the regulation 
of their activity (Darnell, 2002). While HIF-lp is constitutively expressed in the nucleus, 
HIF-1 a translocation to the nucleus is an important step in its regulation and is achieved 
by inhibiting its proteasomal dependent breakdown (Chilov et al., 1999), or increasing its 
synthesis by the PI3K/Akt (Laughner et al., 2001) or p42/p44 MAPK pathways (Mills et 
al., 2009). By separating the nuclear and cytoplasmic portions of cells, it was determined 
the majority of the HIF-1 a protein detected in whole cell lysates resides in the nucleus, 
indicating that regulation of HIF-1 a nuclear translocation did not represent a significant 
barrier to any changes in its activity in keratinocytes harbouring either variant. 
The underlying cause of increased HIF-1 a may stem from any of the mechanisms 
acting on its translation or inhibiting its protein breakdown. Both the classical MAPK and 
PDK/Akt pathways act to induce the translation of HIF-1 a mRNA into protein by 
inducing the eukaryotic translation initiation factor (eIF-4E) and p70S6-kinase that are 
involved in the synthesis of many proteins, including HIF-1 a (Semenza 2003, Sonenberg 
& Gingras, 1998). The underlying cause of HIF-1 a protein accumulation in AAE6- 
transduced cells may result from activation of the MAPK pathway as a L83V substitution 
in the amino acid sequence of E6 (one of those found in AAE6) activates this pathway 
(Chakrabarti et al., 2004). Conversely, some viral oncoproteins inhibit HIF-1 a 
breakdown by direct protein-protein interactions with HIF-1 a itself, the PHDs, or VHL 
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(Cuninghame et al., 2014). AAE6 may bind to any of these proteins may inhibit HIF-la 
breakdown and therefore, increase its protein levels. 
4.3 Hypoxia as a requirement to enhance HIF-1 activity in AAE6 transduced 
keratinocytes 
To assess whether or not the increase in HIF-la protein levels was sufficient to 
induce an increase in transcription of HIF-1 target genes and a Warburg effect, a 
luciferase assay was first used to specifically assess HIF-1 promoter activity. 
Surprisingly, a difference in HIF-1 promoter activity between variants was only observed 
under hypoxia, while no difference was observed between variants for cells assessed 
under normoxia even though a difference in protein levels was found. The requirement 
for hypoxia to induce a difference in promoter activity could be mitigated by factor 
inhibiting hypoxia-inducible factor 1 (FIH-1). FIH-1 is an 02-dependent asparaginyl 
hydroxylase that hydroxylates HIF-1 at Asn-803 under normoxia, preventing it from 
binding to its requisite transcriptional coactivator, p300 (Lando et al., 2002). Therefore, 
while HIF-la protein levels are higher in AAE6-transduced keratinocytes, perhaps a 
functional difference in its promoter activity is not observed due to aspariginyl 
hydroxylation that is relieved only by hypoxia. Future investigations can test this 
hypothesis by using RNA interference directed toward FIH-1 under normoxia and 
observe if the same enhancement of HIF-1 activity is found. Furthermore, the difference 
in activity under hypoxia may be due not to differences in HIF-1 protein levels, but once 
dehydroxylated by repression of FIH-1, the E6 variants may differentially bind to p300. 
HPV16 EPF6 binds to p300 and inhibits its ability to activate p300-responsive promoters, 
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while several mutants of EPE6 do not bind p300 (Patel et al., 1999). A differential ability 
of AAE6 versus that of EPE6 may represent a contributing factor to the difference in 
HIF-1 responsive promoter activity under hypoxia. 
With the knowledge that HIF-1 promoter activity was enhanced under hypoxia, 
the expression of some HIF-1 responsive genes involved in metabolism and angiogenesis 
was then analyzed by RT-qPCR. In agreement with HRE-coupled luciferase assays to 
assess HIF-1 activity, mRNA levels of GLUTl, HK2, LDHA, PDKl and VEGF-A were 
similar between variants under normoxia. Therefore, the second alternative hypothesis, 
that enhanced aerobic glycolysis is due to increased HIF-1 activity, is not supported 
based on gene expression analysis. However, it was found that GLUTl expression was 
significantly higher in AAE6 in comparison to EPE6-transduced keratinocytes under 
hypoxia. The hypoxic response in AAE6 cells was significantly higher for both GLUTl 
and VEGF-A, and slightly increased (albeit not statistically significant) in the case of 
LDHA and PDKl, in comparison to normoxic controls of each variant cell type. Counter- 
intuitive to the lactate production results, LDHA expression was decreased in AAE6 
cells. Since the magnitude of lactate production was higher in Donor Two between AAE6 
and EPE6, future studies can investigate if this difference in LDHA expression is also 
found in Donor Two. These results, coupled with HIF-1 promoter assay investigations, 
suggest that the enhanced ability to induce HIF-1 target genes may represent a possible 
adaptive advantage to the hypoxic tumour microenvironment by the AA variant in 
comparison to EP. This adaptive advantage may partially explain AA’s increased risk for 
the development of high-grade intraepithelial lesions (Xi et al., 2007) and cervical cancer 
(Berumen et al., 2001). HIF-1 expression and activity is associated with enhanced cancer 
60 
progression owing to its ability to increase the expression of several genes (in addition to 
those investigated in this study) involved in cellular proliferation and survival, 
metabolism, epithelial-mesenchymal transition, invasion, and metastasis (reviewed in 
Semenza, 2012). The specific genes and the level of their induction during hypoxia are 
not ubiquitous and human cancers display some variation in the battery of HIF-1 target 
genes induced by hypoxia (Chi et ah, 2006). It is likely that HIF-1 target genes are 
differentially regulated between variant cell types, which may explain why GLUTl is 
expressed to a greater degree under hypoxia in AAE6 cells, but other genes investigated 
were not. 
While the enhanced transcriptional activity of HIF-1 under hypoxia is an 
interesting finding, the similarity in HIF-1 promoter activity and the expression of genes 
involved in metabolism under normoxia suggests that additional mechanisms are likely 
attributable to the enhanced Warburg effect in AAE6-transduced keratinocytes. While 
some mechanisms that induce a Warburg effect can be ruled out as they also act by 
transcription on HIF-1 target genes (e.g., c-myc activation), additional mechanisms may 
be affected by AAE6 that act post-transcriptionally on glycolytic enzymes. For example, 
studies have found activated Akt via the PI3K pathway can induce glucose uptake by 
enhancing GLUTl protein trafficking to the cell membrane, but not affecting its protein 
level (Rathmell et ah, 2003). Active Akt also increases the activity of other glycolytic 
enzymes, such as hexokinase II via post-translational mechanisms (Caimes et al., 2011). 
Since Akt activation also induces HIF-1 a synthesis, this could be an underlying upstream 
mechanism explaining both the Warburg effect and enhanced HIF-1 a protein levels in 
AAE6. 
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As an alternative to Akt-mediated activation of aerobic glycolysis, other 
mechanisms may also be contributing to an enhanced Warburg effect. Regulation of 
PKM2 activity between its highly active tetrameric form and less-active dimeric form can 
be achieved in multiple ways that affect lactate production (Hitosugi et al., 2009). OCT-1 
is a transcription factor that can control pyruvate fate by enhancing transcription of 
metabolic genes not investigated in this study (e.g., PDK4) (Shakya et ah, 2009). 
Conversely, AMP-activated protein kinase (AMPK) may increase lactate production by 
directly activating PDKl activity, without affecting its protein level (Wu et al., 2013). 
Other post-translational modifications on several glycolytic enzymes, such as 
phosphorylation of hexokinase 2, phosphofructokinase-2, pyruvate dehydrogenase and 
LDHA all promote aerobic glycolysis by altering the activity of these enzymes (reviewed 
in Upadhyay et ah, 2013). Furthermore, it has recently been found that lactate production 
can be achieved via increased glutamine consumption and conversion to pyruvate 
through the TCA cycle, representing a potential pathway not reliant on glycolysis for 
lactate production (Koppenol et al., 2011). Collectively, activation of one (or a 
combination) of these pathways may provide alternative explanations for the observed 
aerobic glycolysis found in this study. Nonetheless, the enhanced aerobic glycolysis and 
increased HIF-1 activity under hypoxia by AAE6 found herein represent two novel 
findings that represent potential contributing factors to AA’s enhanced tumourigenic 
capability. 
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5 CONCLUSIONS AND FUTURE DIRECTIONS 
In this study, the glycolytic phenotype of PHFKs transduced with either the AA or 
EP HPV16 E6 oncogene was established. Cells with AAE6 appear to take up more 
glucose and produce more lactate than do EPE6-transduced keratinocytes. Furthermore, a 
potential regulator of this metabolic shift, HIF-1, was also investigated to determine if the 
Warburg effect was the result of enhanced HIF-1 activity. Interestingly, although more 
HIF-1 a protein was detected by Western blotting in AAE6-transduced keratinocytes 
under normoxia, this difference did not result in more HIF-1 activity at the same oxygen 
tension. However, HIF-1 aetivity was significantly increased under hypoxia and the 
response of GLUTl and VEGF-A expression to hypoxia was greater in AAE6-transduced 
keratinocytes. These results suggest that AAE6 may induce an adaptive advantage to 
hypoxia, which is typical of a tumour microenvironment. This adaptive advantage may 
then provide a contribution to the AA variant’s documented increased risk for the 
development of cervieal cancer. 
These results open the door for further investigations regarding the functional 
increase in aerobic glycolysis and HIF-1 activity under hypoxia by AAE6. Firstly, 
inhibition studies on glucose transport using non-hydrolyzable substrates of glucose can 
answer whether or not this metabolic phenotype is a requirement for AAE6’s enhanced in 
vitro capacity for immortalization, transformation, and invasion, as reported previously 
by our group. If this is not the case, a similar approach examining glutamine metabolism 
in variant-transduced cells can be explored, due to an increasing number of reports 
highlighting the significance of glutamine metabolism on lactate production and 
proliferation. Additionally, the enhanced HIF-1 activity under hypoxia should be 
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investigated as to whether or not it has any functional significance regarding AAE6’s 
ability to induce migration and invasion under the hypoxic conditions typical of a tumour 
microenvironment. These follow-up studies will answer whether or not the results 
described in this study have a bearing on AAE6’s enhanced tumourigenicity. 
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822 bits(445) G.O 
titles 
445/445(100%) 0/445(0%) Plus/Plus 
Query 132 C&ArC'r^r’ICAGGACCCAC^GAGCGACCC&Q&AAGT’rACCACAGTS'&TGCACASAGCIGC 161 
, SbjCt 2 CAArG'i”l'TCAGGACCCAcAGeAGCGACCCAaAAAGl'’i'AcCACAGTTATGCACAGAGCTGC 61 
Ouery 162 AAACAAC'fATACATGATA'rAA'rATTAGAATG1'GTG?AC7GCAAGCAACAG'i"rAC1?GCaAC 221 
Sbjet 62 AAACAAC'rATACAXGATAXAA'rAXTAGAATGTGTGf&CTGCAAGCAACAG’s'mCTCCGAC 121 
g«ery 222 G2’GAGG'2ATA?GACrr2GCT'r?TCGGGATTmxaCA?AGTA'rATAGACATGGGAA?CCAT 281 
122 GXGAGGX AXAXG AC’rXTGCX'H'TC.GGG ATTXAXGCAXAGTATATAGAG AXGGG AAXCC At 181 












•TATT 241 AXGCTGXArGXGATAAATGTTXAAAGXXTXAXTCTAAAATXAGTGAGXATAGACAl 
GXX ArAGTTTGTATGGAACAACATXAGAAC ACCAAXAC^CAAi^CGXTGXaXQAX'IXGT 401 





462 ACAAAAAGCAAAGAXTCCATAATAXAAGGGGXCGGXGGACCGGXCGAXGTATGTCXTGTr 621 I f 
362 ACAAAAAGCAAAGATXCCATAAXAXAAGGGGXCGGXGGACCGGTCGAXGmXGTCXXGTr 421 
522 GCAGAXCATCAAGAACACGTAGACiA S4€ 5 ? 
Sb jet 42 2 GCAQATCATCh^QAACACCTM^hm, 4 46 
Figure Al. Sequence alignment of EPE6 with HPV16 reference sequence. E6 DNA 
from Donor One EP transduced keratinocytes was amplified, purified, and sent for 
Sanger sequencing at the Paleo-DNA Laboratory at Lakehead University. A 100% 
alignment between the EPE6 DNA sequence and the reference sequence was found 
confirming EP harboured the reference E6 sequence. 
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Figure A2. Sequence alignment of AAE6 with HPVI6 reference sequence. E6 DNA 
from Donor One AA transduced keratinocytes was amplified, purified, and sent for 
Sanger sequencing at the Paleo-DNA Laboratory at Lakehead University. The expected 5 
highlighted SNPs were found between the AAE6 DNA sequence and the reference 
tVi 
sequence was found confirming AA harboured the Asian-American variant. The 6 
expected SNP couldn’t be confirmed due to it being located within the reverse primer 
sequence and outside the range of the forward primer 
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